Hong Kong, China

Hiu Chi Chong

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Billion King International Limited. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiu Chi Chong. Retrieved from https://idiyas.com/inventor/hiu-chi-chong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hiu Chi Chong: Innovator in Hemoglobin Conjugates

Introduction

Hiu Chi Chong is a notable inventor based in Hong Kong, CN, recognized for his contributions to the field of blood replacement agents and therapeutic proteins. With a total of three patents to his name, Chong has made significant strides in medical innovations that aim to improve patient care.

Latest Patents

Chong's latest patents include "Thiosuccinyl-crosslinked hemoglobin conjugates and methods of use and preparation thereof." This invention provides thiosuccinyl-crosslinked hemoglobin conjugates that are useful as blood replacement agents and therapeutic proteins, along with pharmaceutical compositions comprising these conjugates and the methods of their use and preparation. Another significant patent is "Thiosuccinyl-crosslinked hemoglobin analogs and methods of use and preparation thereof," which details thiosuccinyl-crosslinked hemoglobin analogs that serve as blood replacement agents, along with their pharmaceutical compositions and methods of use and preparation.

Career Highlights

Hiu Chi Chong is currently associated with Billion King International Limited, where he continues to develop innovative solutions in the medical field. His work focuses on enhancing the efficacy and safety of blood replacement therapies.

Collaborations

Chong collaborates with talented individuals in his field, including Kwok Chu Butt and Norman Fung-Man Wai, who contribute to his research and development efforts.

Conclusion

Hiu Chi Chong's innovative work in hemoglobin conjugates represents a significant advancement in medical technology, showcasing his commitment to improving healthcare solutions. His contributions are paving the way for future developments in blood replacement therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…